Apoorva Ambavane

Apoorva Ambavane

Auto-generated profile, based on publicly available information

Apoorva Ambavane

Evidera, Lexington, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAApoorva Ambavane
Apoorva Ambavane
BLBertil Lindahl
Bertil Lindahl
EGEvangelos Giannitsis
Evangelos Giannitsis
JRJulie Roiz
Julie Roiz
JMJoan Mendivil
Joan Mendivil
TITRAPID-AMI investigators
TRAPID-AMI investigators
The 1-hour (h) algorithm triages patients presenting with suspected acute myocardial infarction (AMI) to the emergency department (ED) towards “rule-out,” “rule-in,” or “observation,” depending on baseline and 1-h levels of high-sensitivity cardiac troponin (hs-cTn). The economic consequences of applying the accelerated 1-h algorithm are unknown. We performed a post-hoc economic analysis in a large, diagnostic, multicenter study of hs-cTnT using central adjudication of the final diagnosis by two independent cardiologists. Length of stay (LoS), resource utilization (RU), and predicted diagnostic accuracy of the 1-h algorithm compared to standard of care (SoC) in the ED were estimated. The ED LoS, RU, and accuracy of the 1-h algorithm was compared to that achieved by the SoC at ED discharge. Expert opinion was sought to characterize clinical implementation of the 1-h algorithm, which required blood draws at ED presentation and 1h, after which “rule-in” patients were transferred for coronary angiography, “rule-out” patients underwent outpatient stress testing, and “observation” patients received SoC. Unit costs were for the United Kingdom, Switzerland, and Germany. The sensitivity and specificity for the 1-h algorithm were 87% and 96%, respectively, compared to 69% and 98% for SoC. The mean ED LoS for the 1-h algorithm was 4.3h—it was 6.5h for SoC, which is a reduction of 33%. The 1-h algorithm was associated with reductions in RU, driven largely by the shorter LoS in the ED for patients with a diagnosis other than AMI. The estimated total costs per patient were £2,480 for the 1-h algorithm compared to £4,561 for SoC, a reduction of up to 46%. The analysis shows that the use of 1-h algorithm is associated with reduction in overall AMI diagnostic costs, provided it is carefully implemented in clinical practice. These results need to be prospectively validated in the future.

24 June 2015 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
JWJohn Whalen
John Whalen
JCJ. Chang
J. Chang
IOI. Ozer-Stillman
I. Ozer-Stillman
AAA. Ambavane
A. Ambavane
CNC. Ngai
C. Ngai
Introduction: There is a growing concern that new, high-cost cancer treatment does not necessarily translate into improved outcomes. Several techniques have been used to evaluate the incremental cost/benefit of a new cancer treatment including complex modeling such as cost-effectiveness analysis. This analysis explores a simple, direct measure of the value (cost per month of OS gain) using targeted treatments for mCRC and cost data from France.

24 June 2015 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
JWJ. Whalen
J. Whalen
JCJ. Chang
J. Chang
IOI. Ozer-Stillman
I. Ozer-Stillman
AAA. Ambavane
A. Ambavane
CNC. Ngai
C. Ngai
Introduction: Cost-benefit analyses have been used to evaluate new targeted therapies for cancer, often relying on complex models and extrapolation of overall survival beyond clinical trial follow-up. This exploratory analysis conducts a basic cost-benefit analysis of targeted therapies in mCRC, using a Spanish perspective, based on observed survival in clinical trials.